U.S. market Closed. Opens in 1 day 4 hours 16 minutes

SYNH | Syneos Health, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for SYNH we got that it has weak fundamentals where Valuation is considered to be slightly undervalued, Profitability is unacceptably poor, Growth is on medium level and Health is frighteningly weak.

Valuation (62%)

Company Industry
P/E Ratio (TTM) 16.61 37.46
PEG Ratio (TTM) -0.32 -6.86
P/S Ratio (TTM) 0.83 7.30
P/B Ratio (TTM) 1.27 1.58
P/FCF Ratio (TTM) N/A 23.05
Price to 5YR AVG Earnings Ratio 26.98 128.12
Price to 5YR AVG FCF Ratio 16.43 94.18

Profitability (25%)

Company Industry
ROA (TTM) 3.25% 4.86%
ROE (TTM) 7.72% -1.72%
Net Profit Margin (TTM) 4.94% 10.39%
ROIC 5YR AVG 5.21% 11.06%

Growth (57%)

4QTR AVG 3YR AVG 5YR AVG
EPS -37.84% 203.43% 129.23%
Revenue 0.11% 21.75% 17.35%
Net Income -38.27% 201.64% 128.04%
Cash Flow -65.02% 14.79% -12.16%

Health (28%)

Company Industry
Current Ratio (TTM) 1.13 1.54
Quick Ratio (TTM) 1.13 1.19
D/E Ratio (TTM) 0.83 0.24
Interest Coverage (TTM) 4.99 11.56
Piotroski F-Score 5 5
Altman Z-Score 1.40 12.67
LTL to 5YR AVG FCF 10.43 2.55
Shares Outstanding Growth 5YR AVG 7.53% 1.19%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙